Boston biotech launches organ-chip tech as FDA moves away from animal tests June 10, 2025July 9, 2025 Share More from the Blog The Role of Complex In Vitro Models in IND Submissions to the FDA Read More Insights into the AVA™ Emulation System: Ushering in a New Era of Human-Relevant Drug Discovery Read More Emulate Liver-Chip S1 Accepted into FDA’s ISTAND Pilot Program. What’s Next? Read More Browse All